Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Aug 13, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, corporate-update
TL;DR
Dr. Reddy's filed a 6-K on 8/13/24, standard update for investors.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 13, 2024, to report information as a foreign private issuer. The filing provides standard corporate information and confirms the company's address and contact details in Hyderabad, India. It also indicates that the company files annual reports under Form 20-F.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming Dr. Reddy's status as a foreign private issuer and providing essential corporate contact information.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new material financial or operational information disclosed.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-24-000907 (filing_id) — Accession Number
- 20240813 (date) — Filing Date
- Hyderabad, India (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company has made or is required to make public in its home country.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is August 13, 2024.
Where are Dr. Reddy's Laboratories' principal executive offices located?
Dr. Reddy's Laboratories' principal executive offices are located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates that it files annual reports under cover of Form 20-F.
What is the Commission File Number for Dr. Reddy's Laboratories?
The Commission File Number for Dr. Reddy's Laboratories is 1-15182.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-08-13 10:52:15
Filing Documents
- drr0658_6k.htm (6-K) — 13KB
- drr0658_ex99-1.htm (EX-99.1) — 100KB
- drr0658_ex99-1img01.jpg (GRAPHIC) — 10KB
- drr0658_ex99-1img02.jpg (GRAPHIC) — 5KB
- drr0658_ex99-1img03.jpg (GRAPHIC) — 6KB
- drr0658_ex99-1img04.jpg (GRAPHIC) — 20KB
- 0001575872-24-000907.txt ( ) — 171KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: August 13, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3